文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

外泌体及外泌体微小RNA在前列腺癌放疗中的研究综述

Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-03-27

本文综述外泌体及外泌体微小RNA在前列腺癌进展与放疗反应中的作用。外泌体携带亲代癌细胞遗传与非遗传物质,其微小RNA表达可因放疗等应激改变,具预后与预测生物标志物潜力;尽管分离与表征技术仍有挑战,微小RNA分析进展推动外泌体货物功能研究,助力治疗个体化临床检测开发。

要点

  • 外泌体微小RNA谱可反映前列腺癌侵袭性及放疗反应。
  • 放疗应激可改变癌细胞微小RNA表达并影响外泌体内容物。
  • 外泌体微小RNA有潜力作为预后/预测标志物监测治疗反应。

核心结论

  • 外泌体及外泌体微小RNA有潜力作为前列腺癌预后与预测生物标志物,并用于监测放疗反应和推动治疗个体化。

研究设计与样本

  • 综述,聚焦外泌体及外泌体微小RNA在前列腺癌进展与放疗反应中作用及临床检测开发。

主要发现

  • 外泌体为癌细胞释放的50至150纳米小囊泡,反映亲代癌细胞遗传与非遗传物质。
  • 癌细胞可含不同微小RNA谱,其表达可因放疗等应激改变。
  • 微小RNA影响前列腺肿瘤发生多过程,包括细胞增殖、凋亡诱导、迁移、抑癌基因抑制和放射抵抗。
  • 不同水平外泌体微小RNA比较分析可帮助描绘肿瘤侵袭性与放疗反应。

临床怎么用

  • 可探索外泌体微小RNA谱用于前列腺癌疾病分层、预后预测及放疗反应监测。
  • 临床转化需依赖外泌体分离表征与微小RNA分析技术的进一步成熟。

局限性

  • 外泌体分离与表征仍存在技术挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite current risk stratification systems using traditional clinicopathologic factors, many localized and locally advanced prostate cancers fail radical treatment (ie, radical prostatectomy, radiation therapy with or without androgen deprivation therapy). Therefore, a pressing need exists for enhanced methods of disease stratification through novel prognostic and predictive tools that can reliably be applied in clinical practice. Exosomes are 50- to 150-nm small vesicles released by cancer cells that reflect the genetic and nongenetic materials of parent cancer cells. Cancer cells can contain distinct sets of microRNA profiles, the expression of which can change owing to stress such as radiation therapy. These alterations or distinctions in contents allow exosomes to be used as prognostic and/or predictive biomarkers and to monitor the treatment response. Additionally, microRNAs have been shown to influence multiple processes in prostate tumorigenesis, including cell proliferation, induction of apoptosis, migration, oncogene inhibition, and radioresistance. Thus, comparative exosomal microRNA profiling at different levels could help portray tumor aggressiveness and response to radiation therapy. Although technical challenges persist in exosome isolation and characterization, recent improvements in microRNA profiling have evolved toward in-depth analyses of the exosomal cargo and its functions. We have reviewed the role of exosomes and exosomal microRNAs in biologic processes of prostate cancer progression and radiation therapy response, with a particular focus on the development of clinical assays for treatment personalization.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Malla B, Zaugg K, Vassella E, et al. Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721912. doi:10.1016/j.ijrobp.2017.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。